The table below shows NEOGENOMICS INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$8.14M
-$25.33M
-$25.91M
-$12.69M
-$29.04M
$2.21M
Capital expenditure
$5.00M
$4.50M
$5.58M
$9.93M
$8.22M
$15.83M
Investing cash flow
-$5.00M
$3.56M
$14.53M
$23.74M
$12.05M
-$154.69M
Dividends paid
-
-
-
-
NEO operating cash flow (10-K history)
NEOGENOMICS INC reported operating cash flow of $5.23M for fiscal year 2025. That is down 25.5% from $7.02M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $2.23M (FY 2013) to $5.23M. Figures come from the company's audited annual reports as filed with the SEC.
